Healthcare
Live Price
Offline$354.92
+0.00% today
1Y Change
-15.09%
Window
Jun 23, 2025 → Jun 10, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 10, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ypsomed Holding AG (YPHDF) is a Healthcare stock with a market cap of $3.80B and listed on OTC. The stock last traded around $354.92 and down 15.1% across the available one-year price window (Jun 23, 2025 → Jun 10, 2026). Baseline metrics include revenue growth of +36.5%, EPS growth of +11.7%, a dividend yield of 0.8%. What stands out right now is revenue +36.5%, EPS +11.7%, free cash flow -301.9% with operating margin 18.7% and ROIC 13.7%. The dividend is present but secondary, with a yield around 0.8%. Valuation sits in the middle of the pack at P/E 19.6 and price/sales 4.8. Stock Foundry combines YPHDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
YPHDF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
YPHDF Max Drawdown
-33.75%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for YPHDF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$403.7M
-13.2% YoY
FY Net Income
$5.8M
-74.8% YoY
Free Cash Flow
-$40.8M
+2.3% YoY
Revenue Growth
+36.5%
EPS Growth
+11.7%
Gross Margin
41.2%
Net Margin
24.6%
Income statement
CHF
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 749M | 548M | 497M | 465M | 404M |
| Gross Profit | 292M | 189M | 141M | 114M | 95M |
| Operating Income | 113M | 86M | 37M | 24M | 769K |
| EBITDA | 191M | 162M | 138M | 92M | 64M |
| Net Income | 88M | 78M | 51M | 23M | 6M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CHF
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 36M | 74M | 24M | 16M | 18M |
| Total Assets | 1.3B | 1.1B | 862M | 757M | 718M |
| Total Liabilities | 651M | 484M | 292M | 357M | 314M |
| Shareholder Equity | 680M | 618M | 562M | 393M | 395M |
| Total Debt | 267M | 256M | 157M | 267M | 215M |
| Net Debt | 231M | 182M | 133M | 251M | 197M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
86M
+0.1% YoY
Capital Expenditures
127M
+0.7% YoY
Free Cash Flow
41M
+2.3% YoY
Key ratios
Gross Margin
41.2%
Operating Margin
18.7%
Net Margin
24.6%
ROE
26.9%
Debt / Equity
0.14x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.